ENCOMPASS HEALTH REHABILITATION HOSP — History
CCN 103032 | 3-year financial timeline | COVID resilience: 62/100
🛡️ Public data only — no PHI permitted on this instance.
$32M
Latest Revenue (FY2022)
+8.2%
Revenue CAGR (3yr)
14.9%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $28M | $30M | $32M | +9.0% | +8.2% |
| Operating Expenses | $24M | $26M | $28M | +5.7% | +7.7% |
| Operating Margin | 14.2% | 12.4% | 14.9% | +20.9% | +2.5% |
| Net Income | $4M | $4M | $5M | +31.7% | +10.9% |
| Licensed Beds | 80 | 80 | 80 | +0.0% | +0.0% |
| Total Patient Days | 19,238 | 19,831 | 20,799 | +4.9% | +4.0% |
| Medicare Day % | 74% | 77% | 75% | -2.1% | +0.4% |
| Medicaid Day % | 1% | 1% | 0% | -72.8% | -61.0% |
COVID Impact & Recovery
Resilience Score: 62/100 — Moderate — some COVID impact but recovering
Revenue recovery from FY2020 to FY2022: +17.0% ($28M → $32M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▲ Growing
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+8.2%
This Hospital
+7.6%
State Avg
Latest Margin
14.9%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $35M | 15.3% |
| FY2024 (proj) | $37M | 15.7% |
| FY2025 (proj) | $40M | 16.0% |